| |
CCM group (n = 1761)
|
Control group (n = 3522)
|
|---|
|
Creatinine and electrolyte tests
|
|
Rate 2005-2009
|
55.8%
|
52.4%
|
|
Rate 2010-2013
|
80.7%
|
65.3%
|
|
Beta-blocker therapy
|
|
Rate 2005-2009
|
45.0%
|
43.0%
|
|
Rate 2010-2013
|
65.1%
|
59.5%
|
|
ACE/ARBs therapy
|
|
Rate 2005-2009
|
78.2%
|
76.7%
|
|
Rate 2010-2013
|
81.0%
|
80.2%
|
- Rates of diagnostic and therapeutic indicators in the periods before and after chronic care model (CCM) project implementation among exposed and unexposed subjects. ARBs angiotensin receptor blockers, ACE angiotensin converting enzyme
